Profiles of Monocyte Subsets and Fibrosis-Related Genes in Patients with Muscular Dystrophy Undergoing Intermittent Prednisone Therapy
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26135992 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Asma Chikhaoui und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biomedical Genomics and Oncogenetics (LR16IPT05), Institut Pasteur de Tunis, Université Tunis El Manar, El Manar I, Tunis 2092, Tunisia. Hauptthemen laut MEDLINE: Monocytes, Prednisone, Muscular Dystrophies. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Acip_Myopath, Tunisian Ministry of Higher Education and Scientific Research, Ministry of Higher Education and Scientific Research.
Abstract (Originalsprache)
Muscle dystrophies are a group of genetic disorders characterized by progressive muscle degeneration. Prednisone is a glucocorticoid drug widely used to prevent muscle weakness in these diseases. Despite its known beneficial role, the effect of intermittent delivery on monocytes’ polarization and on dystrophic muscle microenvironment has not yet been thoroughly investigated. In this study, our aim was to identify the phenotype of monocyte subsets in blood and the expression of fibrosis-related genes in dystrophic muscle biopsies in patients receiving intermittent prednisone therapy. We found an increased rate of classical monocytes and a decreased rate of non-classical monocytes that expressed anti-inflammatory marker CD206 in treated patients. In dystrophic muscles, 21 fibrosis-related genes were altered, among which we identified CCAAT/enhancer-binding protein beta CEBPB. Both classical monocytes and CEBPB are known for their roles in stimulating collagen 1 production, a probable marker hampering monocyte/macrophage function. Hence, in some patients with muscular dystrophy, intermittent prednisone treatment could shift the monocytes’ phenotype toward an M2, senescent-like profile. This seems to decrease the inflammatory infiltrate in muscle tissue, an observation that needs to be further confirmed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Biomedical Genomics and Oncogenetics (LR16IPT05), Institut Pasteur de Tunis, Université Tunis El Manar, El Manar I, Tunis 2092, Tunisia.
- Service Orthopédie, Hôpital d'enfant Béchir Hamza, Tunis 1007, Tunisia.
- LR18SP04, Department of Child and Adolescent Neurology, National Institute Mongi Ben Hmida of Neurology, Tunis 1007, Tunisia.
ORCID-Profile: Houda Yacoub-Youssef
Förderung
- Acip_Myopath
- Tunisian Ministry of Higher Education and Scientific Research
- Ministry of Higher Education and Scientific Research
- “Acip_Myopath” project
Zitieren
APA
Chikhaoui, A., Najjar, D., Bouchoucha, S., Boussetta, R., Achour, N. B., Tizaoui, K., Kraoua, I., Turki, I., & Yacoub-Youssef, H. (2025). Profiles of Monocyte Subsets and Fibrosis-Related Genes in Patients with Muscular Dystrophy Undergoing Intermittent Prednisone Therapy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26135992
Vancouver
Chikhaoui A, Najjar D, Bouchoucha S, Boussetta R, Achour NB, Tizaoui K, et al. Profiles of Monocyte Subsets and Fibrosis-Related Genes in Patients with Muscular Dystrophy Undergoing Intermittent Prednisone Therapy. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26135992
BibTeX
@article{Chikhaoui2025,
author = {Chikhaoui, Asma and Najjar, Dorra and Bouchoucha, Sami and Boussetta, Rim and Achour, Nadia Ben and Tizaoui, Kalthoum and Kraoua, Ichraf and Turki, Ilhem and Yacoub-Youssef, Houda},
title = {Profiles of Monocyte Subsets and Fibrosis-Related Genes in Patients with Muscular Dystrophy Undergoing Intermittent Prednisone Therapy},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26135992}
}
EUVIMED